feed,title,long_url,short_url
Benzinga,Liminal BioSciences Outlines Plans To Further Develop Its Lead Compound,https://benzinga.com/general/biotech/22/03/26123810/liminal-biosciences-outlines-plans-to-further-develop-its-lead-compound,https://bit.ly/3MMWcic
Benzinga,Gold Updated Its Highs,https://benzinga.com/news/22/03/26124846/gold-updated-its-highs,https://bit.ly/3MNB3V0
Benzinga,Biogen Posts New Updates Across its Spinraza SMA Research Program,https://benzinga.com/general/biotech/22/03/26123531/biogen-posts-new-updates-across-its-spinraza-sma-research-program,https://bit.ly/3IbQC5k
Benzinga,"Bristol Myers, Nektar Melanoma Doublet Therapy Trial Fails To Show Clinical Benefit",https://benzinga.com/general/biotech/22/03/26120936/bristol-myers-nektar-melanoma-doublet-therapy-trial-fails-to-show-clinical-benefit,https://bit.ly/3t5pDEl
Benzinga,What's Going On With Mullen Automotive Shares Today?,https://benzinga.com/news/22/03/26124612/whats-going-on-with-mullen-automotive-shares-today,https://bit.ly/3tSSCKR
Benzinga,Yum China Stock Slides As COVID-19 Resurgence Disrupts Operations,https://benzinga.com/news/earnings/22/03/26124063/yum-china-stock-slides-as-covid-19-resurgence-disrupts-operations,https://bit.ly/3t9bLcn
